Chris Rallis - Jun 12, 2023 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Director
Signature
/s/ Chris A. Rallis
Stock symbol
FENC
Transactions as of
Jun 12, 2023
Transactions value $
$0
Form type
4
Date filed
6/13/2023, 11:42 AM
Previous filing
May 19, 2023
Next filing
Jul 6, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Stock Option Award $0 +20K +10.57% $0.00 209K Jun 12, 2023 Common shares 20K $8.78 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 12, 2023, Chris Rallis was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan.
F2 The option is 100% vested of date of grant.